Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis

发表于昨天 13:09

期刊：Hepatology

文献作者：Jie Li; Liang Xu; Fajuan Rui; Sally Tran; Pei-Chien Tsai; Youwen Tan; Hidenori Toyoda; Qing-Lei Zeng; Huy Trinh; Yao-Chun Hsu; Tsunamasa Watanabe; Hiroshi Abe; Hiroyuki Motoyama; Yoko Yoshimaru; Takanori Suzuki; Taeang Arai; Masanori Atsukawa; Phillip Vutien; Sebastián Marciano; Xue Bai; Wenjing Ni; Nan Geng; Cheng-Hao Tseng; Jiacheng Liu; Yuqiang Mi; Jing Liu; Yun Ye; Li Zhu; Ru-yue Chen; Chuanwu Zhu; Mayumi Maeda; Joanne Kimiko Liu; Linda Henry; Ming-Lun Yeh; Chung-Feng Huang; Jee-Fu Huang; Chia-Yen Dai; Adrian Gadano; Ramsey Cheung; Wan-Long Chuang; Masaru Enomoto; Yasuhito Tanaka; Shinichi Aishima; Ming-Lung Yu; Chao Wu; Junping Shi; Mindie H. Nguyen

出版日期：2026-5-

DOI号：10.1097/hep.0000000000001442

下载链接：https://journals.lww.com/10.1097/HEP.0000000000001442

文献链接：https://doi.org/10.1097/hep.0000000000001442

当前文献来源于 Ovid Technologies (Wolters Kluwer Health)。

备注信息：

[ovid] Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ovid] Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ovid] Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naive chronic hepatitis B patients with concurrent hepatic steatosis